Old Web
English
Sign In
Acemap
>
Paper
>
A polymorphism in FASL is associated with rituximab response in follicular lymphoma patients.
A polymorphism in FASL is associated with rituximab response in follicular lymphoma patients.
2016
Rocío Gutiérrez-Cívicos
Ana María Hurtado
Daniel Torres-Moreno
José Javier Sánchez-Blanco
Ignacio Español
Luciano Consuegra-Sánchez
Elena Pérez-Ceballos
María Dolores Gutiérrez-Meca
A. Jerez
Pablo Conesa-Zamora
Keywords:
Follicular lymphoma
Diabetes mellitus
Rituximab
Fas ligand
Immunology
Fas Ligand Protein
Medicine
Pharmacogenomic Testing
Polymorphism (computer science)
Correction
Source
Cite
Save
Machine Reading By IdeaReader
5
References
6
Citations
NaN
KQI
[]